TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53

Jiejie Yang,Bin Wang,Qian Xu,Yuling Yang,Lin Hou,Kan Yin,Qingming Guo,Yanan Hua,Li Zhang,Yixuan Li,Jinyu Zhang,Ning Li

DOI: https://doi.org/10.1007/s11010-020-03979-1

IF: 3.842

2020-11-16

Molecular and Cellular Biochemistry

Abstract:Transmembrane protein 166 (TMEM166), an endoplasmic reticulum-associated protein, functions in many diseases via regulating autophagy and/or apoptosis. However, the role of TMEM166 in hepatocellular carcinoma (HCC) remains largely unknown. In this study, we detected the expression of TMEM166 in HCC by real-time fluorescent quantitative PCR (RT-qPCR), immunohistochemistry and western blot. To investigate its biological function and underlying mechanism in HCC, TMEM166 was overexpressed in HCC cell lines and assessed its effects on cell proliferation, migration, invasion, apoptosis and cell cycle by MTT assay, wound healing assay, Transwell assay, Annexin V-FITC/PI assay, JC-1 staining and flow cytometry assay, respectively. Results demonstrated that the expression of TMEM166 was significantly decreased in HCC and was associated with advanced TNM clinical stage and poor clinical outcome of HCC patients. TMEM166 overexpression inhibited HCC cells proliferation, migration and invasion. Furthermore, TMEM166 inhibited cell proliferation by inducing apoptosis and cell cycle arrest via upregulating anti-oncogene <i>TP53</i> and TP53 knockdown significantly alleviated the anti-tumor effects of TMEM166 on HCC cells. This study provides the first comprehensive analysis the role of TMEM166 in HCC. TMEM166 displays a fine anti-tumor activity on HCC cells involving a mechanism of upregulating TP53. This study suggests TMEM166 is a potential target for the treatment of HCC.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of transmembrane protein 166 (TMEM166) in hepatocellular carcinoma (HCC) and its underlying mechanisms. Specifically, the researchers aim to:

1. **Determine the expression pattern of TMEM166 in HCC**: By analyzing data from public databases (such as TCGA) and experimental verification, confirm whether the expression level of TMEM166 in HCC tissues and cell lines is decreased, and explore its relationship with clinicopathological features.

2. **Evaluate the function of TMEM166**: By over - expressing TMEM166 and using methods such as MTT assay, wound - healing assay and Transwell invasion assay, evaluate the impact of TMEM166 on the proliferation, migration and invasion abilities of HCC cells.

3. **Explore the mechanism of action of TMEM166**: By using techniques such as Western Blot, flow cytometry and JC - 1 staining, study how TMEM166 exerts its anti - tumor effect by inducing apoptosis, cell cycle arrest and up - regulating TP53.

4. **Verify the role of TP53 in the anti - tumor function of TMEM166**: By knocking down the TP53 gene, observe its impact on the behavior of HCC cells after TMEM166 over - expression, and further confirm the importance of TP53 as a downstream effector molecule of TMEM166.

In summary, this study aims to comprehensively analyze the biological function of TMEM166 in HCC and its potential therapeutic value, and provide new targets and strategies for the treatment of HCC.